Potential Application of Plant-Derived Compounds in Multiple Sclerosis Management

Area of Science:

• Neuroimmunology
• Pharmacology
• Natural Products Chemistry

Background:

• Multiple sclerosis (MS) is a chronic autoimmune disease causing inflammation, demyelination, and neurodegeneration.
• Current MS treatments focus on immune regulation but have limitations in efficacy and tolerability.
• There is a need for novel therapeutic strategies to manage MS progression and improve patient quality of life.

Purpose of the Study:

• To review the pathogenesis of MS, focusing on the role of inflammation.
• To evaluate the potential of plant-derived compounds as adjunctive therapies for MS.
• To detail the mechanisms of action and clinical potential of these compounds for MS.

Main Methods:

• Literature review of preclinical and clinical studies on plant-derived compounds and MS.
• Analysis of molecular and cellular mechanisms underlying MS pathogenesis.
• Assessment of anti-inflammatory and neuroprotective properties of plant compounds.

Main Results:

• Plant-derived compounds (alkaloids, phenylpropanoids, terpenoids) exhibit significant anti-inflammatory effects.
• These compounds can modulate immune responses relevant to MS.
• Evidence suggests potential for neuroregeneration and symptom attenuation in MS.

Conclusions:

• Plant-derived compounds represent a promising avenue for novel adjunctive therapies in multiple sclerosis.
• Their anti-inflammatory and neuroprotective properties warrant further investigation for MS treatment.
• These natural compounds may offer a valuable addition to current therapeutic approaches for MS.